You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201431 - 201440 of 202331 results
  1. A facile approach for preparing dual agonists with long lifetimes and balanced activities

    SBC: PROLYNX, LLC            Topic: 200

    We have developed a chemically controlled ultra long acting delivery system to support once weekly to once monthly administration of peptides In this system the peptide is covalently attached to a hydrogel microsphere depot by a cleavable eliminative linker upon subcutaneous injection the linker slowly cleaves and releases the drug If the same linker is used to attach two different peptide ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  2. A long acting parathyroid hormone (PTH) 1-34 for treatment of hypoparathyroidism

    SBC: PROLYNX, LLC            Topic: 200

    A long acting parathyroid hormone PTH(1-34) for treatment of hypoparathyroidism Project Summary Hypoparathyroidism is a rare endocrine disorder characterized by low calcium (Ca2+) and high phosphate (Pi) levels in the setting of absent or low parathyroid hormone (PTH). Overall, an estimated 60,000 to 115,000 individuals in the United States have chronic hypoparathyroidism; most cases (~75%) result ...

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  3. Cryo-EM Sample Handling

    SBC: EXPRESSLO LLC            Topic: 28a

    The Nobel prize in chemistry recently awarded to Dubochet, Frank, and Henderson, for developing cryo-electron microscopy methods for high resolution structure determination in biomolecules is a testament to cryo-electron microscopy’s importance. While cryo-electron microscopy resolution, imaging cameras, and data analysis methods have developed considerably over the years, the preparation and ha ...

    SBIR Phase I 2020 Department of Energy
  4. Cryo-EM Sample Handling

    SBC: EXPRESSLO LLC            Topic: C4928a

    The Nobel prize in chemistry recently awarded to Dubochet, Frank, and Henderson, for developing cryo-electron microscopy methods for high resolution structure determination in biomolecules is a testament to cryo-electron microscopy’s importance. While cryo-electron microscopy resolution, imaging cameras, and data analysis methods have developed considerably over the years, the preparation and ha ...

    SBIR Phase II 2022 Department of Energy
  5. Mobile oral cancer screening system for low-resource settings

    SBC: LIGHT RESEARCH INC.            Topic: 102

    Two-thirds of oral and oropharyngeal squamous cell carcinoma (OSCC) occur in low- and middle-income countries (LMICs), the 5-year survival rate is only 10-40. Enough is already known about the disease and its prevention for action to be taken. The poor survival rate in LMICs is mainly due to late diagnosis. Therefore, it is imperative to detect precursor and malignant lesions early and expeditious ...

    SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
  6. SBIR TOPIC 431- MOBILE ORAL-CANCER SCREENING AND TREATMENT (MOST) SYSTEM FOR LOW-RESOURCE SETTINGS

    SBC: LIGHT RESEARCH INC.            Topic: 431

    Oral and oropharyngeal squamous cell carcinoma (OSCC) together rank as the sixth most common cancer worldwide, it is the most common cancer in some low- and middle- income countries (LMICs). The poor survival rate in LMICs and rural regions in developed countries is mainly due to late diagnosis and the resultant progression of disease to an advanced stage at diagnosis. Motivated by the successes i ...

    SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  7. High-resolution reflective microscope

    SBC: LIGHT RESEARCH INC.            Topic: NIBIB

    The goal of this SBIR project is to develop and commercialize a fundamentally new type of all-reflective microscope (ARM) without any obscuration for full spectrum applications from ultraviolet (UV) to infrared (IR). In Phase I stage, Light Research Inc (LRI) will demonstrate ARM by designing, prototyping, and characterizing a high numerical aperture (NA) reflective objective and tubing lens. Curr ...

    SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  8. Synthetic Calibrators for Immunohistochemical Assays

    SBC: BOSTON CELL STANDARDS INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The broad, long-term objective of this Phase II grant proposal is to improve accuracy of breast cancer diagnosis. Specifically, this Phase II grant proposal is for clinical testing of a new technology that will prom

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Clinical Validation of ER/PR Test Controls & Calibrators

    SBC: BOSTON CELL STANDARDS INC.            Topic: N/A

    DESCRIPTION (provided by applicant) Phase I The long-term objective of this project is to improve the consistency and standardization of clinical cancer diagnostic testing of tissue biopsies. There are increasing numbers of cancer therapeutics that ar

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Clinical Validation of ER/PR Test Controls & Calibrators

    SBC: BOSTON CELL STANDARDS INC.            Topic: N/A

    DESCRIPTION (provided by applicant) Phase I The long-term objective of this project is to improve the consistency and standardization of clinical cancer diagnostic testing of tissue biopsies. There are increasing numbers of cancer therapeutics that are linked to immunohistochemical diagnostic tests. Patient therapy is directly affected by the quantitative results of such testing. The absence o ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government